Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sampson

Showing results (331-340 of 393) with videos related to

Pageof 40
Sort By:
Neurosurgical Focus|May 20, 2006
Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studiesSandeep Kunwar, Susan M Chang, Michael D Prados, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant gliomaJennifer A Quinn, Sara Xiaoyin Jiang, David A Reardon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2007
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study GroupSandeep Kunwar, Michael D Prados, Susan M Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Phase II trial of Gliadel plus O6-benzylguanine in adults with recurrent glioblastoma multiformeJennifer A Quinn, Sara Xiaoyin Jiang, James Carter, et al.
Journal of Neuro-Oncology|September 23, 2011
Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningiomaDavid A Reardon, Andrew D Norden, Annick Desjardins, et al.
Radiation Research|July 14, 2022
Age and Sex Divergence in Hematopoietic Radiosensitivity in Aged Mouse Models of the Hematopoietic Acute Radiation SyndromeAndrea M Patterson, Sasidhar Vemula, P Artur Plett, et al.
Journal of Neuro-Oncology|January 25, 2007
Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomasAnnick Desjardins, Jennifer A Quinn, James J Vredenburgh, et al.
HIV Clinical Trials|October 27, 2010
Development of diagnostic criteria for serious non-AIDS events in HIV clinical trialsAlan R Lifson, , Waldo H Belloso, et al.
Neuro-Oncology|October 5, 2001
Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomasS Gururangan, L Cokgor, J N Rich, et al.
Neuro-Oncology|April 17, 2007
Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusionsJohn H Sampson, Raghu Raghavan, Martin L Brady, et al.
Pageof 40

Showing results (331-340 of 393) with videos related to

Sort By:
Pageof 40
Neurosurgical Focus|May 20, 2006
Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studiesSandeep Kunwar, Susan M Chang, Michael D Prados, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant gliomaJennifer A Quinn, Sara Xiaoyin Jiang, David A Reardon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2007
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study GroupSandeep Kunwar, Michael D Prados, Susan M Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Phase II trial of Gliadel plus O6-benzylguanine in adults with recurrent glioblastoma multiformeJennifer A Quinn, Sara Xiaoyin Jiang, James Carter, et al.
Journal of Neuro-Oncology|September 23, 2011
Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningiomaDavid A Reardon, Andrew D Norden, Annick Desjardins, et al.
Radiation Research|July 14, 2022
Age and Sex Divergence in Hematopoietic Radiosensitivity in Aged Mouse Models of the Hematopoietic Acute Radiation SyndromeAndrea M Patterson, Sasidhar Vemula, P Artur Plett, et al.
Journal of Neuro-Oncology|January 25, 2007
Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomasAnnick Desjardins, Jennifer A Quinn, James J Vredenburgh, et al.
HIV Clinical Trials|October 27, 2010
Development of diagnostic criteria for serious non-AIDS events in HIV clinical trialsAlan R Lifson, , Waldo H Belloso, et al.
Neuro-Oncology|October 5, 2001
Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomasS Gururangan, L Cokgor, J N Rich, et al.
Neuro-Oncology|April 17, 2007
Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusionsJohn H Sampson, Raghu Raghavan, Martin L Brady, et al.
Pageof 40